EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cannabinoid-Inspired Inhibitors of the SARS-CoV-2 Coronavirus 2′-O-Methyltransferase (2′-O-MTase) Non-Structural Protein (Nsp10–16)

Menny M Benjamin iD, George S Hanna iD, Cody F Dickinson iD, Yeun-Mun Choo iD, Xiaojuan Wang iD, Jessica A Downs-Bowen iD, Ramyani De iD, Tamara R McBrayer, Raymond F Schinazi iD, Sarah E Nielson iD, Joan M Hevel iD, Pankaj Pandey iD und 7 weitere

Molecules · 2024

DOI: 10.3390/molecules29215081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Menny M Benjamin und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, 280 Calhoun St, Charleston, SC 29425, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, Viral Nonstructural Proteins, Methyltransferases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCCIH NIH HHS, NIGMS NIH HHS, NIH NIGMS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The design and synthesis of antiviral compounds were guided by computationally predicted data against highly conserved non-structural proteins (Nsps) of the SARS-CoV-2 coronavirus. Chromenephenylmethanone-1 (CPM-1), a novel biphenylpyran (BPP), was selected from a unique natural product library based on in silico docking scores to coronavirus Nsps with high specificity to the methyltransferase protein (2′-O-MTase, Nsp10–16), which is responsible for viral mRNA maturation and host innate immune response evasion. To target the 2′-O-MTase, CPM-1, along with intermediate BPP regioisomers, tetrahydrophenylmethanones (TPMs), were synthesized and structurally validated via nuclear magnetic resonance (NMR) data and DP4+ structure probability analyses. To investigate the activity of these BPPs, the following in vitro assays were conducted: SARS-CoV-2 inhibition, biochemical target validation, mutagenicity, and cytotoxicity. CPM-1 possessed notable activity against SARS-CoV-2 with 98.9% inhibition at 10 µM and an EC50 of 7.65 µM, as well as inhibition of SARS-CoV-2’s 2′-O-MTase (expressed and purified) with an IC50 of 1.5 ± 0.2 µM. In addition, CPM-1 revealed no cytotoxicity (CC50 of >100 µM) or mutagenicity (no frameshift or base-pair mutations). This study demonstrates the potential of computational modeling for the discovery of natural product prototypes followed by the design and synthesis of drug leads to inhibit the SARS-CoV-2 2′-O-MTase.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antiviral AgentsViral Nonstructural ProteinsMethyltransferasesMolecular Docking SimulationHumansCannabinoidsCOVID-19 Drug TreatmentCOVID-19Enzyme InhibitorsViral Regulatory and Accessory Proteins

Stichwörter der Autor:innen

2′-O-MTaseDP4+ NMR analysesNspSARS-CoV-2cannabinoidcomputational screencoronavirusin silicomethyltransferasenatural productsnon-structural protein

Substanzen

Antiviral AgentsViral Nonstructural ProteinsMethyltransferasesCannabinoidsEnzyme InhibitorsViral Regulatory and Accessory ProteinsNSP16 protein, SARS-CoV-2ORF1ab polyprotein, SARS-CoV-2

Autor:innen und Institutionen

  • Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, 280 Calhoun St, Charleston, SC 29425, USA.
  • Department of Chemistry, University of Malaya, Kuala Lumpur 50603, Malaysia.
  • Department of Pharmacy, Lanzhou University, Lanzhou 730000, China.
  • Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, 1760 Haygood Drive, HSRB-1, Atlanta, GA 30322,…
  • Department of Chemistry & Biochemistry, Logan, UT 84322, USA.
  • National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, USA.

ORCID-Profile: Menny M Benjamin, George S Hanna, Cody F Dickinson, Yeun-Mun Choo, Xiaojuan Wang, Jessica A Downs-Bowen, Ramyani De, Raymond F Schinazi, Sarah E Nielson, Joan M Hevel, Pankaj Pandey, Robert J Doerksen, Danyelle M Townsend, Lucas Bialousow

Förderung

  • NCCIH NIH HHS
  • NIGMS NIH HHS
  • NIH NIGMS
  • South Carolina SmartState Program

Zitieren

APA

Benjamin, M. M., Hanna, G. S., Dickinson, C. F., Choo, Y. M., Wang, X., Downs-Bowen, J. A., De, R., McBrayer, T. R., Schinazi, R. F., Nielson, S. E., Hevel, J. M., Pandey, P., Doerksen, R. J., Townsend, D. M., Zhang, J., Ye, Z., Wyer, S., Bialousow, L., & Hamann, M. T. (2024). Cannabinoid-Inspired Inhibitors of the SARS-CoV-2 Coronavirus 2′-O-Methyltransferase (2′-O-MTase) Non-Structural Protein (Nsp10–16). Molecules. https://doi.org/10.3390/molecules29215081

Vancouver

Benjamin MM, Hanna GS, Dickinson CF, Choo YM, Wang X, Downs-Bowen JA, et al. Cannabinoid-Inspired Inhibitors of the SARS-CoV-2 Coronavirus 2′-O-Methyltransferase (2′-O-MTase) Non-Structural Protein (Nsp10–16). Molecules. 2024. doi:10.3390/molecules29215081

BibTeX
@article{Benjamin2024,
  author = {Benjamin, Menny M and Hanna, George S and Dickinson, Cody F and Choo, Yeun-Mun and Wang, Xiaojuan and Downs-Bowen, Jessica A and De, Ramyani and McBrayer, Tamara R and Schinazi, Raymond F and Nielson, Sarah E and Hevel, Joan M and Pandey, Pankaj and Doerksen, Robert J and Townsend, Danyelle M and Zhang, Jie and Ye, Zhiwei and Wyer, Scott and Bialousow, Lucas and Hamann, Mark T},
  title = {Cannabinoid-Inspired Inhibitors of the SARS-CoV-2 Coronavirus 2′-O-Methyltransferase (2′-O-MTase) Non-Structural Protein (Nsp10–16)},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29215081}
}
Kostenlos starten →